THE STUDY OF THE EFFECT OF CANDESARTAN CILEXETIL AND RESVERATROL ON THE MOLECULAR AND BIOLOGICAL PARAMETERS IN VITRO AND IN VIVO
https://doi.org/10.51523/2708-6011.2014-11-4-20
Abstract
Objective: to analyze the effect of candesartan cilexetil and resveratrol of different dosages and combinations on the molecular and biological parameters of cell culture from bone marrow of mice and cytogenetic parameters of peripheral blood of the animals after physical activity. Material and methods. The cell culture from the bone marrow of C57Bl/6, Balb/C and ICR mice was used for the experiment. We analyzed the number of stem cells with CD117+ phenotype and the molecular and biological parameters (flow cytometry). The statistical processing of the data was performed using «Excel» and «Statistica», 6.0. Results. It was shown that the combined application of candesartan cilexetil and resveratrol increased the number of stem cells with CD117+ and had a stimulating effect on the proliferative processes in vitro and in vivo .
About the Authors
A. V. Beliayeva
Institute of Bioorganic Chemistry NAS of Belarus, Minsk
Belarus
Belarus
V. Yu. Afonin
Institute of Bioorganic Chemistry NAS of Belarus, Minsk
Belarus
Belarus
M. V. Anisovich
Institute of Bioorganic Chemistry NAS of Belarus, Minsk
Belarus
Belarus
References
1. Литвинчук, С. Глобальное бремя артериальной гипертензии. Мировая статистика / С. Литвинчук // Medicine Review. - 2009. - № 4. - С. 6-11.
2. Finegold, J. A. Mortality from ischaemic heart disease by country, region, and age: Statistic from World Health Organization and United Nationals / J. A. Finegold, P. Asaria, D. P. Francis // Int J Cardiol. - 2013. - Vol. 168, № 2. - P. 934-945.
3. Newcomer, J. W. Antipsychotic medications: metabolic and cardiovascular risk / J. W. Newcomer // J. Clinical Psychiatry. - 2007. - Vol. 68. № 4. - P. 8-13.
4. Endogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart disease / T. Watanabe [et al.] // Sensors. - 2012. - Vol. 12, № 4. - P. 4974-4985.
5. Nickens, M. A. Cardiovascular disease in pregnancy / M. A. Nickens, R. C. Long, S. A. Geraci // South Med J. - 2013. - Vol. 106, № 11. - P. 624-630.
6. апреля - День профилактики болезней сердца [Электронный ресурс]. - 2012. - Режим доступа: www.28gp.by/index. php?page=edz12_hd. - Дата доступа: 26.01.2013.
7. De Rosa, M. L. Candesartan improves maximal exercise capacity in hypertensives: results of a randomized placebo-controlled crossover trial / M. L. De Rosa, M. Chiariello // J Clin Hypertens. - 2009. - Vol. 11, № 4. - P. 192-200.
8. Possible mechanism for the anemia induced by candesartan cilexetil (TCV-116), an angiotensin II receptor antagonist, in rats / I. Naeshiro [et al.] // Eur J Pharmacol. - 1998. - Vol. 354, № 2/3. - P. 179-187.
9. Ресвератрол - ресвератол для сердца [Электронный ресурс]. - 2010. - Режим доступа: http://uvenal.ucoz.ru/index/resveratrol_dlja_serdca/0-17. - Дата доступа: 16.10.2012.
10. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes / M. Jang [et al.] // Science. - 1997. - Vol. 275, № 5297. - P. 218-220.
11. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease / S. Karuppagounder [et al.] // Neurochem. Int. - 2009. - Vol. 54, № 2. - P. 111-118.
12. Wu, J. M. Cardioprotection by resveratrol: a review of effects/targets in cultured cells and animal tissues / J. M. Wu, Tze-chen Hsiesh, Z. Wang // Am J Cardiovasc Dis. - 2011. - Vol. 1, № 1. - P. 38-47.
Review
For citations:
Beliayeva A.V., Afonin V.Yu., Anisovich M.V. THE STUDY OF THE EFFECT OF CANDESARTAN CILEXETIL AND RESVERATROL ON THE MOLECULAR AND BIOLOGICAL PARAMETERS IN VITRO AND IN VIVO. Health and Ecology Issues. 2014;(4):106-111. (In Russ.) https://doi.org/10.51523/2708-6011.2014-11-4-20
Views: 305
Email this article 